We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Cardiovascular

Menopause and stroke risk

Absolute increase is small. Modifiable factors (BP, lipids, glucose) matter more.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Key points

  • Transdermal preferred
  • Manage BP + glucose
  • Small absolute risk

Frequently asked questions

Am I at higher risk on HRT?

Formulation- and dose-dependent.

How to lower risk?

Manage BP, glucose, weight, sleep.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.